Screener
Sutro Biopharma STRO Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's invested capital?
- Sutro Biopharma (STRO) reported invested capital of -$126.94M in Q1 2026.
- How has Sutro Biopharma's invested capital changed year-over-year?
- Sutro Biopharma's invested capital decreased by 14.7% year-over-year, from -$110.64M to -$126.94M.
- What is the long-term trend for Sutro Biopharma's invested capital?
- Over 5 years (2020 to 2025), Sutro Biopharma's invested capital has grown at a -0.7% compound annual growth rate (CAGR), from $181.14M to -$174.91M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Sutro Biopharma's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude